GlassScriptPhysician profile
Daniel P Hardin
NPI 1467613000
$659.99
in general payments reported to CMS, 2019-2025
10 companies · $16.78 in 2025
The $16.78 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.10 · 2021: $102 · 2022: $141 · 2023: $204 · 2024: $159 · 2025: $16.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $515.13 | 2021-2024 | Freestyle Libre 3, Mitraclip, Amplatzer Talisman |
| Dexcom, INC. | $20.19 | 2024 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $19.37 | 2023 | Watchman Flx |
| Shockwave Medical, INC | $17.93 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.57 | 2024 | Jardiance |
| Exact Sciences Corporation | $16.78 | 2025 | Cologuard Collection Kit |
| Biotronik INC. | $15.92 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.94 | 2019 | |
| Pfizer INC. | $12.23 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hardin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.